Vital Signs: HIV Transmission Along the Continuum of Care - United States, 2016
Overview
Affiliations
Background: In 2016, an estimated 1.1 million persons had human immunodeficiency virus (HIV) infection in the United States; 38,700 were new infections. Knowledge of HIV infection status, behavior change, and antiretroviral therapy (ART) all prevent HIV transmission. Persons who achieve and maintain viral suppression (achieved by most persons within 6 months of starting ART) can live long, healthy lives and pose effectively no risk of HIV transmission to their sexual partners.
Methods: A model was used to estimate transmission rates in 2016 along the HIV continuum of care. Data for sexual and needle-sharing behaviors were obtained from National HIV Behavioral Surveillance. Estimated HIV prevalence, incidence, receipt of care, and viral suppression were obtained from National HIV Surveillance System data.
Results: Overall, the HIV transmission rate was 3.5 per 100 person-years in 2016. Along the HIV continuum of care, the transmission rates from persons who were 1) acutely infected and unaware of their infection, 2) non-acutely infected and unaware, 3) aware of HIV infection but not in care, 4) receiving HIV care but not virally suppressed, and 5) taking ART and virally suppressed were 16.1, 8.4, 6.6, 6.1, and 0 per 100 person-years, respectively. The percentages of all transmissions generated by each group were 4.0%, 33.6%, 42.6%, 19.8%, and 0%, respectively.
Conclusion: Approximately 80% of new HIV transmissions are from persons who do not know they have HIV infection or are not receiving regular care. Going forward, increasing the percentage of persons with HIV infection who have achieved viral suppression and do not transmit HIV will be critical for ending the HIV epidemic in the United States.
Harrison S, Hung P, Green K, Miller S, Paton M, Ahuja D BMC Public Health. 2025; 25(1):926.
PMID: 40057737 PMC: 11889868. DOI: 10.1186/s12889-025-22090-y.
Interventions during Early Infection: Opening a Window for an HIV Cure?.
Hiner C, Mueller A, Su H, Goldstein H Viruses. 2024; 16(10).
PMID: 39459922 PMC: 11512236. DOI: 10.3390/v16101588.
The study of acceptability HIV self-testing among Iranian injecting drug users: a qualitative study.
Khazaee-Pool M, Dolan K, Bolbanabad A, Nili S, Ponnet K, Pashaei T BMC Public Health. 2024; 24(1):2939.
PMID: 39443945 PMC: 11500424. DOI: 10.1186/s12889-024-20260-y.
Zamantakis A, Merle J, Queiroz A, Zapata J, Deskins J, Pachicano A Implement Sci Commun. 2024; 5(1):111.
PMID: 39380128 PMC: 11462864. DOI: 10.1186/s43058-024-00638-0.
Addressing Methamphetamine Use Is Essential to Stopping HIV Transmission.
Black F, Finn B, McMahan V, Vanessa M, Xochitl L, Marti X J Acquir Immune Defic Syndr. 2024; 98(2):e9-e10.
PMID: 39374037 PMC: 11804937. DOI: 10.1097/QAI.0000000000003542.